Valuation Vivos Therapeutics, Inc.
Stocks
VVOS
US92859E2072
Medical Equipment, Supplies & Distribution
|
Market Closed -
Nasdaq
16:00:00 2026-08-27 EDT
|
5-day change | 1st Jan Change | ||
| 0.2584 USD | +1.81% |
|
-7.42% | -87.27% |
| 08-20 | Vivos Therapeutics Opens Nevada Sleep Treatment Center | MT |
| 08-20 | Vivos Therapeutics Opens New Sleep Testing and Treatment Facility in Nevada | CI |
Company Valuation: Vivos Therapeutics, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|
| Market Cap 1 | 51.78 | 9.251 | 14.89 | 25.27 | 18.25 | 5.198 | - |
| Change | - | -82.13% | 61% | 69.64% | -27.79% | -71.51% | - |
| Enterprise Value (EV) | 51.78 | 9.251 | 14.89 | 25.27 | 18.25 | 5.198 | 5.198 |
| Change | - | -82.13% | 61% | 69.64% | -27.79% | -71.51% | 0% |
| P/E | -2.34x | -0.39x | -1.12x | -1.93x | -0.98x | -0.19x | -0.31x |
| PBR | - | - | 36.9x | 3.18x | -12.7x | - | - |
| PEG | - | -0.05x | 0x | 0x | 0.15x | 0x | 0x |
| Capitalization / Revenue | 3.07x | 0.58x | 1.08x | 1.68x | 1.05x | 0.24x | 0.15x |
| EV / Revenue | 0x | 0x | 0x | 0x | 0x | 0.24x | 0.15x |
| EV / EBITDA | - | -0x | - | - | -0x | -0.28x | -9.38x |
| EV / EBIT | -0x | -0x | -0x | -0x | -0x | -0.25x | -0.42x |
| EV / FCF | - | - | - | - | - | - | - |
| FCF Yield | - | - | - | - | - | - | - |
| Dividend per Share 2 | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - |
| EPS 2 | -24 | -26 | -11.14 | -2.22 | -2.07 | -1.342 | -0.8233 |
| Distribution rate | - | - | - | - | - | - | - |
| Net sales 1 | 16.88 | 16.02 | 13.8 | 15.03 | 17.44 | 21.79 | 34.09 |
| EBITDA 1 | - | -24.36 | - | - | -18.58 | -18.72 | -0.554 |
| EBIT 1 | -20.38 | -25.03 | -17.3 | -11.17 | -19.89 | -20.41 | -12.34 |
| Net income 1 | -20.29 | -23.84 | -13.58 | -11.14 | -21.17 | -23.53 | -14.7 |
| Net Debt | - | - | - | - | - | - | - |
| Reference price 2 | 56.2500 | 10.0500 | 12.4400 | 4.2900 | 2.0300 | 0.2584 | 0.2584 |
| Nbr of stocks (in thousands) | 920 | 920 | 1,197 | 5,890 | 8,988 | 20,118 | - |
| Announcement Date | 3/31/22 | 3/30/23 | 3/28/24 | 3/31/25 | 4/15/26 | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.19x | - | - | - | 5.11M | |
| 73.25x | 7.71x | 44.95x | -.--% | 12.72B | |
| 21.59x | 2.14x | 10.71x | 2.12% | 7B | |
| 33.09x | 6.9x | 18.66x | 1.15% | 6.53B | |
| 31.14x | 1.48x | 9.28x | -.--% | 5.47B | |
| 34.12x | 10.11x | 25.57x | 0.59% | 5.14B | |
| 18.09x | 2.98x | 15.57x | 3.47% | 3.91B | |
| -14.3x | 2.72x | -16.04x | - | 2.08B | |
| -18.85x | 462.99x | -82.85x | -.--% | 1.87B | |
| 21.34x | 2.56x | 9.24x | 2.01% | 1.7B | |
| Average | 19.93x | 55.51x | 3.90x | 1.17% | 4.64B | |
| Weighted average by Cap. | 36.34x | 23.78x | 18.08x | 0.96% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- VVOS Stock
- Valuation Vivos Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
